Leading economic indicators

FILE - This April 23, 2008, file photo, shows the Altria Group Inc. corporate headquarters in Richmond, Va. The potential entry of one of the world’s largest tobacco companies into the marijuana business is sending the shares of Cronos group rocketing this morning. Cronos is a Canadian cannabis company, which confirmed late Monday, Dec. 3, 2018, that it is in talks with Altria group about a possible investment. (AP Photo/Steve Helber, File)
December 04, 2018 - 10:36 am
TORONTO (AP) — Curiosity from one the world's largest tobacco companies about the marijuana business sent shares of a Canadian cannabis company higher at the opening bell Tuesday. Cronos Group confirmed talks late Monday with Marlboro maker Altria about a possible investment. Altria Group Inc.,...
Read More
FILE- In this Nov. 28, 2018, file photo trader Michael Milano works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Tuesday, Dec. 4. (AP Photo/Richard Drew, File)
December 04, 2018 - 10:17 am
U.S. stocks declined in early trading Tuesday, giving up many of the market's gains from a day earlier. Losses in banks, technology stocks and industrial companies outweighed gains elsewhere in the market. Homebuilders slumped on renewed concerns that the outlook for home sales is dimming. Bond...
Read More
A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Tuesday, Dec. 4, 2018. Asian shares were mostly lower Tuesday as investors wondered if a 90-day tariff truce was enough for the U.S. and China to resolve a range of issues from technology development to trade. (AP Photo/Ahn Young-joon)
December 04, 2018 - 7:49 am
LONDON (AP) — Global stock markets gave up Tuesday many of the gains they recorded in the previous session when a 90-day trade tariff truce between the U.S. and China shored up investor sentiment. KEEPING SCORE: In Europe, Germany's DAX was down 0.8 percent to 11,377 while France's CAC 40 fell 0.8...
Read More
A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Tuesday, Dec. 4, 2018. Asian shares were mostly lower Tuesday as investors wondered if a 90-day tariff truce was enough for the U.S. and China to resolve a range of issues from technology development to trade. (AP Photo/Ahn Young-joon)
December 04, 2018 - 5:28 am
SINGAPORE (AP) — World markets were mostly lower on Tuesday on doubts that a 90-day truce in a tariff battle will allow the U.S. and China to resolve issues ranging from technology development to trade. The dollar fell against the Japanese yen. KEEPING SCORE: In Europe, Germany's DAX shed 0.8...
Read More
A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Tuesday, Dec. 4, 2018. Asian shares were mostly lower Tuesday as investors wondered if a 90-day tariff truce was enough for the U.S. and China to resolve a range of issues from technology development to trade. (AP Photo/Ahn Young-joon)
December 04, 2018 - 2:35 am
SINGAPORE (AP) — Asian shares were mostly lower Tuesday as traders questioned whether a 90-day truce in a tariff battle will allow the U.S. and China to resolve issues ranging from technology development to trade. KEEPING SCORE: Japan's Nikkei 225 index gave up 2.4 percent to 22,036.05 and the...
Read More
Trader Vincent Napolitano works on the floor of the New York Stock Exchange, Monday, Dec. 3, 2018. Stocks are opening sharply higher on Wall Street, following gains in overseas markets after the U.S. and China struck a 90-day truce in their trade dispute. (AP Photo/Richard Drew)
December 03, 2018 - 10:27 pm
SINGAPORE (AP) — Asian shares were mostly lower Tuesday as investors wondered if a 90-day tariff truce was enough for the U.S. and China to resolve a range of issues from technology development to trade. KEEPING SCORE: Japan's Nikkei 225 index shed 0.7 percent in early trading to 22,418.87 and the...
Read More
FILE- In this Nov. 28, 2018, file photo final inspector Mary Skinner inspects the rear end of a General Motors Chevrolet Cruze at Jamestown Industries in Youngstown, Ohio. On Monday, Dec. 3, the Institute for Supply Management, a trade group of purchasing managers, issues its index of manufacturing activity for November. (AP Photo/Tony Dejak, File)
December 03, 2018 - 10:55 am
WASHINGTON (AP) — U.S. manufacturers expanded at a faster pace in November as new orders surged, a positive sign for domestic economic growth heading into 2019. The Institute for Supply Management, an association of purchasing managers, said Monday its manufacturing index rose to 59.3 last month...
Read More
FILE- In this Thursday, Nov. 29, 2018, file photo trader Dennis Maguire, left, works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Monday, Dec. 3. (AP Photo/Richard Drew, File)
December 03, 2018 - 9:41 am
NEW YORK (AP) — The latest on developments in financial markets (all times local): 9:35 a.m. Stocks are opening sharply higher on Wall Street, following gains in overseas markets after the U.S. and China struck a 90-day truce in their trade dispute. The Dow Jones Industrial Average jumped more than...
Read More
FILE- In this July 24, 2013, file photo a security guard walks in front of the GlaxoSmithKline building in Shanghai, China. Shares of Tesaro soared early Monday, Dec. 3, 2018, after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker. (AP Photo/Eugene Hoshiko, File)
December 03, 2018 - 9:37 am
Shares of Tesaro soared Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker. Glaxo plans to pay $75 per share for Tesaro, which makes the ovarian cancer treatment Zejula. That represents a premium of more than 60 percent to the stock's $46.38...
Read More
December 03, 2018 - 8:43 am
Shares of Tesaro soared early Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker. Glaxo plans to pay $75 per share for Tesaro, which makes the ovarian cancer treatment Zejula. That represents a premium of more than 60 percent to the stock's $46.38...
Read More

Pages